IDXX
2024Q1BMOIDEXX Laboratories Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH
Street
Consensus EPS2.67
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move2.0%
IV front—
P/C full—
P/C front—
Features as of2024-04-30
Run-up
Close—
Ret 5d-0.2%
Ret 10d+0.7%
Ret 20d-5.5%
Ret 30d-7.0%
Actual EPS
2.81Beat
Estimated EPS2.67
Actual revenue
964.1M
Surprise %+5.2%
Beat / missBeat
Beat streak 44
Beat streak 87
Reaction
1-day stock reaction-1.0%
Implied vs actual
Implied 2.0%Actual 4.0%
Gap reaction-4.0%
Day result-5.0%
Next-day upNo
Realized / IV1.96×
Post tape
Post 5d+4.1%
Post 10d+17.2%
Post volume1.0M
Vol ×10d2.02×
Vol ×20d2.19×
Post range4.9%